Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archna Bajaj

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Opinion in Lipidology|April 26, 2020
Homozygous familial hypercholesterolemia: what treatments are on the horizon?Archna Bajaj, Marina Cuchel
The Lancet. Diabetes & Endocrinology|October 7, 2024
Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factorsMarina Cuchel, Archna Bajaj
Journal of Atherosclerosis and Thrombosis|April 25, 2022
Advancements in the Treatment of Homozygous Familial HypercholesterolemiaArchna Bajaj, Marina Cuchel
Journal of Clinical Lipidology|February 15, 2026
Lipoprotein(a) testing in an outpatient cardiology clinic: A quality improvement initiativeJadry Gruen, Archna Bajaj
European Heart Journal|July 13, 2022
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?Archna Bajaj, Marina Cuchel
Nature Medicine|April 7, 2020
Antisense oligonucleotides for atherosclerotic diseaseArchna Bajaj, Daniel J Rader
Journal of the American College of Cardiology|May 3, 2023
Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?Daniel J Rader, Archna Bajaj
The American Journal of Clinical Nutrition|September 15, 2017
Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?Archna Bajaj, Daniel J Rader
Nature Medicine|July 24, 2025
Targeting triglyceride-rich lipoproteins in cardiovascular diseaseArchna Bajaj, Daniel J Rader
Nature Reviews. Cardiology|April 27, 2026
Base editing and silencing of PCSK9 shows clinical promise in humansArchna Bajaj, Daniel J Rader
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Opinion in Lipidology|April 26, 2020
Homozygous familial hypercholesterolemia: what treatments are on the horizon?Archna Bajaj, Marina Cuchel
The Lancet. Diabetes & Endocrinology|October 7, 2024
Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factorsMarina Cuchel, Archna Bajaj
Journal of Atherosclerosis and Thrombosis|April 25, 2022
Advancements in the Treatment of Homozygous Familial HypercholesterolemiaArchna Bajaj, Marina Cuchel
Journal of Clinical Lipidology|February 15, 2026
Lipoprotein(a) testing in an outpatient cardiology clinic: A quality improvement initiativeJadry Gruen, Archna Bajaj
European Heart Journal|July 13, 2022
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?Archna Bajaj, Marina Cuchel
Nature Medicine|April 7, 2020
Antisense oligonucleotides for atherosclerotic diseaseArchna Bajaj, Daniel J Rader
Journal of the American College of Cardiology|May 3, 2023
Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?Daniel J Rader, Archna Bajaj
The American Journal of Clinical Nutrition|September 15, 2017
Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?Archna Bajaj, Daniel J Rader
Nature Medicine|July 24, 2025
Targeting triglyceride-rich lipoproteins in cardiovascular diseaseArchna Bajaj, Daniel J Rader
Nature Reviews. Cardiology|April 27, 2026
Base editing and silencing of PCSK9 shows clinical promise in humansArchna Bajaj, Daniel J Rader
Pageof 4